MedTrace Logo

Study of Prognosis of Follicular Lymphoma Through a Prospective Collection of Data (F2-study)

NCT01250223 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1093

Last updated 2020-07-09

No results posted yet for this study

Summary

The F2-study is a complement of the previous studies of the Follicular Lymphoma Prognostic Factors Project which permitted the development of the Follicular Lymphoma International Prognostic Index (FLIPI).

The F2-study is designed as a prospective collection of information potentially useful to predict the prognosis of newly diagnosed Follicular Lymphoma patients, and its purposes are to validate the FLIPI and to verify whether a prognostic collection of data would allow the development of a more accurate prognostic index.

Conditions

  • Lymphoma, Follicular

Sponsors & Collaborators

  • Fondazione Italiana Linfomi - ETS

    collaborator OTHER

  • The International Non-Hodgkin Lymphoma Prognostic Factor Project

    collaborator OTHER

  • Associazione Angela Serra per la ricerca sul cancro

    lead OTHER

Principal Investigators

  • Massimo Federico, MD · Dip. Oncologia, Ematologia e Patologie dell'Apparato Respiratorio - Università di Modena e Reggio Emilia, Modena, Italy

  • Philippe Solal-Céligny, MD · Centre Jean Bernard, Le Mans, France

  • Armando Lopez-Guillermo, MD · Institut d'Hematologia i Oncologia, Hospital Clinic, Barcelona, Spain

  • Peter McLaughlin, MD · UT MD Anderson Cancer Ctr, Houston, TX, USA

  • Umberto Vitolo, MD · Azienda Universitaria Ospedaliera San Giovanni Battista, Torino, Italy

  • Stefano A. Pileri, MD · Instituto Seragnoli, Unità Operativa di Emolinfopatologia, Università di Bologna, Bologna, Italy

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-02-28
Primary Completion
2008-05-31
Completion
2016-12-31

Countries

  • United States
  • Argentina
  • Czechia
  • France
  • Italy
  • Spain
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01250223 on ClinicalTrials.gov